Robert A. Michael
CHIEF EXECUTIVE OFFICER at AbbVie Inc.
Sits on 1 board. Last updated September 27, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2025
2 years of board service in total across 1 board, counting each seat separately. Longest: AbbVie Inc., 1 year.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
AbbVie Inc. May 8, 202693.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 27, 2026 | AbbVie Inc. | Shares withheld for tax | −36,523 | $232.08 | $8,476,258 |
| Feb 18, 2026 | AbbVie Inc. | Grant or award | +33,833 | — | — |
| Feb 18, 2026 | AbbVie Inc. | Grant or award | +12,030 | — | — |
| Feb 18, 2026 | AbbVie Inc. | Grant or award | +14,452 | — | — |
| Feb 18, 2026 | AbbVie Inc. | Grant or award | +22,124 | — | — |
| Feb 28, 2025 | AbbVie Inc. | Shares withheld for tax | −27,186 | $205.02 | $5,573,674 |
| Feb 13, 2025 | AbbVie Inc. | Grant or award | +24,732 | — | — |
| Feb 13, 2025 | AbbVie Inc. | Grant or award | +10,146 | — | — |
| Feb 13, 2025 | AbbVie Inc. | Grant or award | +12,030 | — | — |
| Feb 13, 2025 | AbbVie Inc. | Grant or award | +14,454 | — | — |
| Feb 29, 2024 | AbbVie Inc. | Option exercise | +11,420 | $61.36 | $700,731 |
| Feb 29, 2024 | AbbVie Inc. | Option exercise | +10,140 | $54.86 | $556,280 |
| Feb 29, 2024 | AbbVie Inc. | Open-market sale | −21,560 | $176.44 | $3,804,046 |
| Feb 29, 2024 | AbbVie Inc. | Open-market sale | −47,319 | $176.46 | $8,349,911 |
| Feb 28, 2024 | AbbVie Inc. | Shares withheld for tax | −37,638 | $178.99 | $6,736,826 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.